
AstraZeneca Pharma India Ltd surrenders marketing authorisation for Olaparib 100mg and 150mg
AstraZeneca Pharma India Limited had earlier announced the receipt of Marketing Authorisation dated November 17, 2023 for Olaparib film-coated tablets 100mg and 150mg (Lynparza) which was indicated in combination with Abiraterone and Prednisone or …